Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7497 - 7504 of 12099 results
ClassCo, Inc. v. Apple, Inc.: A Reminder Of Obviousness Analysis Under KSR
January 6, 2017| Blog| Viewpoint
Outlook 2017: New Year May Bring Stark Reform, ACA Repeal, Heavy Dose of Uncertainty
January 6, 2017| News
Medicare Drug Benefit's Catastrophic Spending Up Sharply
January 6, 2017| News
New York City Enacts Nation’s First Freelance Worker Protection Law
January 5, 2017| Blog| Viewpoint
Health Care Enforcement Review and 2017 Outlook: Major Case Developments
January 5, 2017| Blog| Viewpoint
New York Delays Cybersecurity Rules for Banks/Insurers Until March 1, 2017
January 5, 2017| Blog| Viewpoint
Health Care Enforcement Review & 2017 Outlook: Important Case Law Developments
January 5, 2017| Advisory| Viewpoint
Health Care Enforcement Review and 2017 Outlook: FDA's Wide-Ranging Activities
January 4, 2017| Blog| Viewpoint
News & Press Releases
Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement
August 18, 2025
Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.
Mintz advised the underwriters in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE
August 15, 2025
Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|